Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial) Read more
IIT Kanpur researchers map structure of key Cell Receptor, enabling targeted drug development Read more
Rubicon Research files for IPO with SEBI, Targets ₹10,850 Million to drive growth and innovation Read more
Fischer Medical Ventures partners with Bio Angle Vacs Sdn Bhd’s in science, technology and marketing Read more